C12N 2795/14021
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2795/14021 (Viruses as such) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 5
- Assignees
- 6
- Inventors
- 16
- Latest grant
- 20 Jun 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Antibacterial phage, phage peptides and methods of use thereof20 Jun 2017US 9,682,110 B2Technophage,Investigacao E Desenvolvimento Em Biotechnologia, SA
- Antibacterial phage, phage peptides and methods of use thereof15 Sep 2015US 9,134,312 B2Technophage, InvestigaçãO E Desenvolvimento Em Biotecnologia, SA
- A clinical isolated avirulent strain protects against wildtype virulent clostridioides difficile infection23 Oct 2025US 2025/0325599 A1The University of Chicago
- Peptide targeting fusobacteria, composition for diagnosing cancer comprising same, and drug delivery composition5 Dec 2024US 2024/0402182 A1Industry-Academic Cooperation Foundation, Yonsei University
- Antibacterial Phage, Phage Peptides and Methods of Use Thereof28 Jan 2016US 2016/0022747 A1Technophage, InvestigaçãO E Desenvolvimento Em Biotecnologia, SA
- Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages17 Apr 2014US 2014/0106982 A1
- Antibacterial phage, phage peptides and methods of use thereof1 Mar 2012US 2012/0052048 A1Technophage, InvestigaçãO E Desenvolvimento Em Biotecnologia, SA
Most cited
By later US patents